Walker, E., Shukla, S., & Gupta, S.(2018).Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.Cancer Letters,430, 25-33.
Shankar, E., Kanwal, R., Goel, A., Yang, X., Shukla, S., MacLennan, G., Fu, P., Madabhushi, A., Ramakrishnan, P., & Gupta, S.(2017).Abstract 1080: Targeting the PI3K-Akt and NF-?B pathways as a combination therapy in blocking prostate cancer progression.Cancer Research,77(13 Supplement),1080-1080.
Shankar, E., Kanwal, R., Goel, A., Yang, X., Shukla, S., MacLennan, G., Fu, P., Liu, H., Madabhushi, A., & Gupta, S.(2017).PD33-02 PROSTATE CANCER AGGRESSIVENESS IS MEDIATED BY AKT AND NF-?B SIGNALING PATHWAYS: A SYSTEMS BIOLOGY APPROACH.The Journal of Urology,197(4).
Weiss, M., Avva, J., Soebiyanto, R., Loparo, K. A., Shukla, S. A., Gupta, S. A., & Sreenath, S. N.(2008).Complex Systems Biology of Prostate Cancer..
